Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) (NCT05464030)

🧪 Interventions in This Study

• M9140 (DRUG)
• M9140 (DRUG)
• Bevacizumab (DRUG)
• Capecitabine (DRUG)
• 5-fluorouracil (5-FU) (DRUG)
• Folinic acid (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (35 Sites)

Showing the first 25 of 35 sites.

• California Cancer Associates for Research & Excellence, Inc. — Encinitas, California
• California Cancer Associates for Research & Excellence, Inc. — Fresno, California
• Rhode Island Hospital — Providence, Rhode Island
• Mary Crowley Cancer Research — Dallas, Texas
• MD Anderson Cancer Center - Oncology — Houston, Texas
• NEXT Oncology — San Antonio, Texas
• The Ottawa Hospital Cancer Centre — Ottawa,
• University Health Network - Princess Margaret Cancer Centre — Toronto,
• National Cancer Center Hospital - Dept of Gastroenterology — Chūōku,
• National Cancer Center Hospital East — Kashiwa-shi,
• Saitama Cancer Center — Kitaadachi-gun,
• Cancer Institute Hospital of JFCR — Kōtoku,
• Aichi Cancer Center Hospital — Nagoya,
• Kindai University Hospital — Osakasayama-shi,
• Shizuoka Cancer Center — Sunto-gun,
• Kanagawa Cancer Center — Yokohama,
• Kyungpook National University Chilgok Hospital — Daegu,
• National Cancer Center — Goyang-si,
• Seoul National University Bundang Hospital — Seongnam,
• Asan Medical Center — Seoul,
• Samsung Medical Center — Seoul,
• Seoul National University Hospital — Seoul,
• Severance Hospital, Yonsei University Health System — Seoul,
• Hospital Clinic de Barcelona — Barcelona,
• Hospital del Mar — Barcelona,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Colorectal Cancer

• Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes — Los Angeles, California
• A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — Duarte, California
• Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) — Houston, Texas
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver — Basking Ridge, New Jersey
• The PRIME-CRC Trial to Promote CRC Screening in Rural Communities — Bastrop, Louisiana
• Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer — Concord, California

Explore by condition: All Colorectal Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.